tradingkey.logo
tradingkey.logo
Search

Mangoceuticals Inc

MGRX
Add to Watchlist
0.370USD
0.0000.00%
Close 06/30, 16:00ETQuotes delayed by 15 min
6.28MMarket Cap
LossP/E TTM

More Details of Mangoceuticals Inc Company

Mangoceuticals, Inc. is focused on developing men’s and women’s health and wellness products and services via a secure telemedicine platform. The Company connects consumers to licensed healthcare professionals through its Website at www.MangoRX.com, for the provision of care via telehealth on its customer portal. It has developed and is commercially marketing a brand of erectile dysfunction (ED) products under the brand name Mango, a brand of hair-loss products under the brand name Grow, a brand of hormone balance and therapy products under the name Mojo, and a brand of weight-loss products under the brand name Slim. The Mango ED product includes the three ingredients: Either Sildenafil (the active ingredient in Viagra) or Tadalafil (the active ingredient in Cialis), and Oxytocin. Mango GROW includes four ingredients: Minoxidil (the active ingredient in Rogaine) and Finasteride (the active ingredient in Propecia), Vitamin D3 and Biotin, which are available as dietary supplements.

Mangoceuticals Inc Info

Ticker SymbolMGRX
Company nameMangoceuticals Inc
IPO dateMar 21, 2023
CEOCohen (Jacob D)
Number of employees- -
Security typeOrdinary Share
Fiscal year-endMar 21
Address15110 Dallas Pkwy, Suite 600
CityDALLAS
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code75248
Phone18336264679
Websitehttps://www.mangorx.com/
Ticker SymbolMGRX
IPO dateMar 21, 2023
CEOCohen (Jacob D)

Company Executives of Mangoceuticals Inc

Name
Name/Position
Position
Shareholding
Change
Dr. Kenny Myers
Dr. Kenny Myers
Independent Non-Executive Director
Independent Non-Executive Director
136.67K
--
Mr. Eugene M. Johnston
Mr. Eugene M. Johnston
Chief Financial Officer
Chief Financial Officer
120.00K
--
Mr. Alex P. Hamilton
Mr. Alex P. Hamilton
Independent Non-Executive Director
Independent Non-Executive Director
3.33K
+49.01%
Mr. Jacob D. Cohen
Mr. Jacob D. Cohen
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Ms. Lorraine Dalessio, Esq.
Ms. Lorraine Dalessio, Esq.
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Name
Name/Position
Position
Shareholding
Change
Dr. Kenny Myers
Dr. Kenny Myers
Independent Non-Executive Director
Independent Non-Executive Director
136.67K
--
Mr. Eugene M. Johnston
Mr. Eugene M. Johnston
Chief Financial Officer
Chief Financial Officer
120.00K
--
Mr. Alex P. Hamilton
Mr. Alex P. Hamilton
Independent Non-Executive Director
Independent Non-Executive Director
3.33K
+49.01%
Mr. Jacob D. Cohen
Mr. Jacob D. Cohen
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Ms. Lorraine Dalessio, Esq.
Ms. Lorraine Dalessio, Esq.
Independent Non-Executive Director
Independent Non-Executive Director
--
--

FAQs

Who are the top five shareholders of Mangoceuticals Inc?

The top five shareholders of Mangoceuticals Inc are: Dr. Kenny Myers

How many institutions hold shares of Mangoceuticals Inc (MGRX)?

As of 2026Q1, 37 institutions hold shares of Mangoceuticals Inc, with a combined market value of approximately 2.67M, accounting for 15.75% of the total shares. Compared to 2025Q4, institutional shareholding has increased by 2145026.00.